Home World News

World News

Latest

First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...

Ogkologos - December 4, 2023

Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer

Ogkologos - December 1, 2023

EMA Recommends Extending Indications for Pembrolizumab to Patients with Advanced Biliary...

Ogkologos - December 1, 2023

Learning to Live With Cancer: A Survivor’s Story

Ogkologos - November 30, 2023

Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder...

Ogkologos - November 30, 2023

FDA Amends Indication for Pembrolizumab in the First-Line Treatment for Patients...

Ogkologos - November 30, 2023

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

Ogkologos - November 29, 2023

A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...

Ogkologos - November 29, 2023

Qué debo saber sobre los programas de emparejamiento de ensayos clínicos...

Ogkologos - November 28, 2023

Efficacy of Rituximab Maintenance in Patients with Mantle Cell Lymphoma Who...

Ogkologos - November 28, 2023

12 3...332 Page 1 of 332

MOST POPULAR

Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer

May 21, 2024

POT1 Mutations Associated with Long Telomere Length Confer a Predisposition to...

May 17, 2023

Liquid Biopsy Detects Brain Cancer and Early-Stage Kidney Cancer

July 23, 2020

Toothbrushes and ctDNA: Exciting early detection concepts from new teams formed...

May 11, 2022

HOT NEWS

Common anti-inflammatory drug could boost cancer immunotherapy

Shannen Doherty Opens Up About Life After Cancer And BH90210

EMA Recommends Extension of Therapeutic Indications for Durvalumab

Telephone-Based Rehab Program Helps People with Advanced Cancer Maintain Independence